Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Liver fibrosis occurs as a wound-healing response to chronic hepatic injuries irrespective of the underlying etiology and may progress to life-threatening cirrhosis. Here we show that CCN1, a matricellular protein of the CCN (CYR61/CTGF/NOV) family, is accumulated in hepatocytes of human cirrhotic livers. CCN1 is not required for liver development or regeneration, since these processes are normal in mice with hepatocyte-specific Ccn1 deletion. However, Ccn1 expression is upregulated upon liver injuries and functions to inhibit liver fibrogenesis induced by either carbon tetrachloride intoxication or bile duct ligation and promote fibrosis regression. CCN1 acts by triggering cellular senescence in activated hepatic stellate cells and portal fibroblasts by engaging integrin α6β1 to induce reactive oxygen species accumulation through the RAC1-NADPH oxidase 1 enzyme complex, whereupon the senescent cells express an antifibrosis genetic program. Mice with hepatocyte-specific Ccn1 deletion suffer exacerbated fibrosis with a concomitant deficit in cellular senescence, whereas overexpression of hepatic Ccn1 reduces liver fibrosis with enhanced senescence. Furthermore, tail vein delivery of purified CCN1 protein accelerates fibrosis regression in mice with established fibrosis. These findings reveal a novel integrin-dependent mechanism of fibrosis resolution in chronic liver injury and identify the CCN1 signaling pathway as a potential target for therapeutic intervention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“activation of the matricellular protein CCN1 was shown to induce senescence during skin and liver repair (Jun and Lau, 2010; Kim et al., 2013).”
From An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA (2014) · cites this paper as Kim et al., 2013
In the citing paper
“Cellular senescence contributes to the maintenance of the structure and the function of tissues following injury.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [146]
In the citing paper
“in liver fibrosis, a condition associated with scarring of the liver and decrease in its function, senescence limits the proliferation and expansion of ECM-producing activated hepatic stellate cells145,146. This response limits the progression of the pathology following liver damage.”
From Cellular senescence in ageing: from mechanisms to therapeutic opportunities (2021) · cites this paper as [146]
In the citing paper
“and accelerate fibrosis resolution in chronic inflammatory injuries by inducing senescence in myofibroblasts through integrin α6β1. [ 12 , 16 ]”
From Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis (2022) · cites this paper as [16]
In the citing paper
“In the liver, CCN1 can promote biliary regeneration after cholestasis by inducing cholangiocyte proliferation”
From Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis (2022) · cites this paper as [16]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Cellular senescence: when bad things happen to good cells
Campisi, J., & d'Adda di Fagagna, F. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2233 · Cited by 4,441 · cited 1×
“Cellular senescence is a form of irreversible cell cycle arrest that occurs in response to cellular stresses such as DNA damage, oxidative stress, oncogene activation, chromatin disruption, and telomere erosion (47, 48).”
BackgroundFour faces of cellular senescence
Rodier, F., & Campisi, J. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201009094 · Cited by 2,070 · cited 1×
“Whereas senescence is a well-recognized mechanism of tumor suppression, emerging evidence indicates that it may play a role in aging, tissue repair, and even malignancy (12).”
BackgroundSenescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027 · cited 5×
“Although a previous report (11) has suggested that senescence can limit fibrosis, this emerging concept has been tested only in CCl4-induced injury in the liver.”
BackgroundInfluentialPathogenesis of Liver Fibrosis
Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809
Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA
Liu, F., Song, Y. K., & Liu, D. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300947 · Cited by 1,727 · cited 1×
“using a hydrodynamic delivery method (23).”
Cellular senescence in cancer and aging.
Collado, M., Blasco, M. A., & Serrano, M. (2007) · Cell · doi:10.1016/j.cell.2007.07.003 · Cited by 1,708 · cited 2×
“Cellular senescence is a form of irreversible cell cycle arrest that occurs in response to cellular stresses such as DNA damage, oxidative stress, oncogene activation, chromatin disruption, and telomere erosion (47, 48).”
BackgroundDebacq-Chainiaux, F., Erusalimsky, J. D., Campisi, J., & Toussaint, O. (2009) · Nature Protocols · doi:10.1038/nprot.2009.191 · Cited by 1,668
Postic, C., Shiota, M., Niswender, K. D., Jetton, T. L., Chen, Y., Moates, J. M., Shelton, K. D., Lindner, J., Cherrington, A. D., & Magnuson, M. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.305 · Cited by 1,302 · cited 1×
“Ccn1 Hep mice were generated by crossing Ccn1 mice with Alb-Cre mice (18) (Jackson Laboratory) expressing Cre recombinase under the control of the albumin promoter.”
MethodJun, J.-I., & Lau, L. F. (2010) · Nature Cell Biology · doi:10.1038/ncb2070 · Cited by 998 · cited 2×
“A high level of ROS may lead to DNA damage response and the activation of a p53- and p16/pRb-dependent pathway of cellular senescence (16, 48).”
BackgroundMethodSelf-citationMyofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805 · cited 1×
“notype (9, 10) or enter a senescence state (11), leading to the”
BackgroundProlonged bile duct obstruction: a new experimental model for cirrhosis in the rat.
Kountouras, J., Billing, B. H., & Scheuer, P. J. (1984) · PubMed Central · Cited by 667
Sato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1396 · Cited by 609 · cited 1×
“Explorations of approaches that drive hepatic myofibroblasts into senescence, including the delivery of genetic information or chemical regulators targeting HSCs (56) and PFs, might prove informative in the development of novel therapeutic strategies for the treatment of liver fibrosis.”
BackgroundA reproducible and well-tolerated method for 2/3 partial hepatectomy in mice
Mitchell, C., & Willenbring, H. (2008) · Nature Protocols · doi:10.1038/nprot.2008.80 · Cited by 577 · cited 1×
“A 2/3 partial hepatectomy was performed on normal male mice according to published protocol (24).”
MethodTaking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets
Jun, J.-I., & Lau, L. F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3599 · Cited by 568 · cited 5×
“Consequently, monitoring CCN2 levels is being developed as a potential diagnostic tool for kidney, lung, and liver fibrosis (14).”
BackgroundInfluentialSelf-citationDeactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Troeger, J. S., Mederacke, I., Gwak, G., Dapito, D. H., Mu, X., Hsu, C. C., Pradere, J., Friedman, R. A., & Schwabe, R. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.036 · Cited by 515 · cited 1×
“notype (9, 10) or enter a senescence state (11), leading to the”
BackgroundRegulation of Nox and Duox enzymatic activity and expression
Lambeth, J. D., Kawahara, T., & Diebold, B. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.03.028 · Cited by 495 · cited 1×
“There are four NOX isoforms in mouse cells in addition to the more distantly related DUOX1 and DUOX2 (43).”
BackgroundModified assay for determination of hydroxyproline in a tissue hydrolyzate
Edwards, C. A., & O'Brien, W. D. (1980) · Clinica Chimica Acta · doi:10.1016/0009-8981(80)90192-8 · Cited by 476 · cited 1×
“dried liver tissue according to a previously published protocol (29).”
BackgroundThe role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis
Elsharkawy, A. M., Oakley, F., & Mann, D. A. (2005) · Apoptosis · doi:10.1007/s10495-005-1055-4 · Cited by 419 · cited 1×
“The termination of fibrogenesis in liver injury may occur in part when ECM-producing myofibroblasts are purged by undergoing apoptosis or senescence (11, 37), and thus defects in these processes may result in enhanced fibrosis in Ccn1 Hep mice.”
BackgroundCYR61 (CCN1) Is Essential for Placental Development and Vascular Integrity
Mo, F.-E., Muntean, A. G., Chen, C.-C., Stolz, D. B., Watkins, S. C., & Lau, L. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8709-8720.2002 · Cited by 416 · cited 2×
“Since Ccn1 is essential for cardiovascular development, germ line Ccn1 knockout mice are embryonic lethal (33, 34).”
BackgroundSelf-citationDNA excision in liver by an albumin-Cre transgene occurs progressively with age
Postic, C., & Magnuson, M. A. (2000) · genesis · doi:10.1002/(sici)1526-968x(200002)26:2<149::aid-gene16>3.0.co;2-v · Cited by 369
Kireeva, M. L., Mo, F.-E., Yang, G. P., & Lau, L. F. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.4.1326 · Cited by 341 · cited 1×
“For CCN1 treatment, 40 g of purified recombinant CCN1 protein (22) was diluted in 1 ml saline solution and injected through the tail vein at 6 ml/min.”
MethodSelf-citationCCN1/CYR61: the very model of a modern matricellular protein
Lau, L. F. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0778-3 · Cited by 338 · cited 3×
“Here we show that CCN1, a matricellular protein of the CCN (CYR61/CTGF/NOV) family, is accumulated in hepatocytes of human cirrhotic livers.”
BackgroundSelf-citationAoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336 · cited 1×
“Both NOX1 and NOX2 expressed in HSCs have been found to play key roles in liver fibrosis (44, 45), and GKT137831, a NOX1/4 inhibitor, curbs the fibrogenic response in HSCs and attenuates liver fibrosis in mice (53, 54).”
BackgroundHepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Taura, K., Miura, K., Iwaisako, K., Österreicher, C. H., Kodama, Y., Penz-Österreicher, M., & Brenner, D. A. (2010) · Hepatology · doi:10.1002/hep.23368 · Cited by 336
Li, Z., Dranoff, J. A., Chan, E. P., Uemura, M., Sévigny, J., & Wells, R. G. (2007) · Hepatology · doi:10.1002/hep.21792 · Cited by 335 · cited 2×
“PFs were isolated from the hepatic hila according to a published protocol (27) and were confirmed by immunocytochemical analysis for -SMA and elastin (Abcam).”
BackgroundMethodEpithelial‐to‐mesenchymal transitions in the liver†
Choi, S. S., & Diehl, A. M. (2009) · Hepatology · doi:10.1002/hep.23196 · Cited by 307 · cited 1×
“Bone marrow-derived cells and epithelial cells may also differentiate into myofibroblasts (5, 6), although the extents of their contribution to liver fibrosis have been controversial (7, 8).”
BackgroundChen, C.-C., Chen, N., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008087200 · Cited by 305
Self-citationThe Angiogenic Factor Cyr61 Activates a Genetic Program for Wound Healing in Human Skin Fibroblasts
Chen, C.-C., Mo, F.-E., & Lau, L. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107666200 · Cited by 300
Self-citationNox1-dependent Reactive Oxygen Generation Is Regulated by Rac1
Cheng, G., Diebold, B. A., Hughes, Y., & Lambeth, J. D. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512751200 · Cited by 277 · cited 1×
“The engagement of 6 1 by CCN1 in human skin fibroblasts activates the small G-protein RAC1 (41), which can serve multiple functions, including acting as an activating subunit of the NOX complex to induce the generation of ROS (42).”
BackgroundConnective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
Gressner, O. A., & Gressner, A. M. (2008) · Liver International · doi:10.1111/j.1478-3231.2008.01826.x · Cited by 270
Cellular senescence controls fibrosis in wound healing
Jun, J.-I., & Lau, L. F. (2010) · Aging · doi:10.18632/aging.100201 · Cited by 255 · cited 1×
“CCN1 is an angiogenic inducer involved in skin wound healing and bone fracture repair (32, 46).”
BackgroundSelf-citationJiang, J. X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schröder, K., Brandes, R. P., Devaraj, S., & Török, N. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.007 · Cited by 251 · cited 1×
“Both NOX1 and NOX2 expressed in HSCs have been found to play key roles in liver fibrosis (44, 45), and GKT137831, a NOX1/4 inhibitor, curbs the fibrogenic response in HSCs and attenuates liver fibrosis in mice (53, 54).”
BackgroundModeling Liver Fibrosis in Rodents
Constandinou, C., Henderson, N., & Iredale, J. P. (2005) · Fibrosis Research · doi:10.1385/1-59259-940-0:237 · Cited by 247 · cited 2×
“twice weekly for 6 weeks to induce liver fibrosis (20).”
BackgroundMethodWhat's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis
Iwaisako, K., Brenner, D. A., & Kisseleva, T. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2011.07002.x · Cited by 219 · cited 1×
“The perisinusoidal hepatic stellate cells (HSCs) are the primary precursor cells that transdifferentiate into proliferative, ECMproducing myofibroblast-like cells when activated upon liver injury, whereas portal fibroblasts (PFs) also undergo myofibroblastic differentiation and play significant roles in fibrosis resul…”
BackgroundNox enzymes as novel targets for drug development
Lambeth, J. D., Krause, K.-H., & Clark, R. A. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0123-6 · Cited by 212
Paik, Y.-H., Iwaisako, K., Seki, E., Inokuchi, S., Schnabl, B., Österreicher, C. H., Kisseleva, T., & Brenner, D. A. (2011) · Hepatology · doi:10.1002/hep.24281 · Cited by 204 · cited 2×
“Thus, although NOX1-induced ROS have been shown to promote HSC activation and stimulate liver fibrogenesis (44, 45), they may also be critical for the regression of fibrosis.”
BackgroundChen, N., Chen, C.-C., & Lau, L. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003040200 · Cited by 195 · cited 2×
“To test whether CCN1 induces senescence and limits fibrosis by acting through binding 6 1 in vivo, we utilized Ccn1 dm/dm knock-in mice in which the Ccn1 genomic locus has been replaced by the Dm allele, which encodes a CCN1 mutant disrupted in the 6 1 binding sites (17, 38).”
BackgroundMethodSelf-citationCurrent status of novel antifibrotic therapies in patients with chronic liver disease
Cohen-Naftaly, M., & Friedman, S. L. (2011) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x11413002 · Cited by 186 · cited 1×
“A broad range of antifibrosis therapies, including various means of eliminating the causes of injury, reducing inflammation, inhibiting HSC activation and fibrogenesis, and promoting HSC apoptosis, are currently under development (55).”
BackgroundOxidative stress in alcoholic liver disease: Role of NADPH oxidase complex
Minicis, S. D., & Brenner, D. A. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.05277.x · Cited by 154 · cited 1×
“The accumulation of ROS in HSCs contributes to their activation and fibrogenic response, and several clinical trials are currently testing the efficacy of antioxidants in reversing liver fibrogenesis (52).”
BackgroundIsolation and Culture of Hepatic Stellate Cells
Weiskirchen, R., & Gressner, A. M. (2005) · Fibrosis Research · doi:10.1385/1-59259-940-0:099 · Cited by 145 · cited 1×
“HSCs were isolated from normal adult male mice as described previously (26).”
MethodCytotoxicity of TNFα is regulated by integrin‐mediated matrix signaling
Chen, C., Young, J. L., Monzon, R. I., Chen, N., Todorović, V., & Lau, L. F. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601596 · Cited by 143 · cited 2×
“To test whether CCN1 induces senescence and limits fibrosis by acting through binding 6 1 in vivo, we utilized Ccn1 dm/dm knock-in mice in which the Ccn1 genomic locus has been replaced by the Dm allele, which encodes a CCN1 mutant disrupted in the 6 1 binding sites (17, 38).”
MethodSelf-citationThe opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis
Yoon, P. O., Lee, M.-A., Cha, H., Jeong, M. H., Kim, J., Jang, S. P., Choi, B. Y., Jeong, D., Yang, D. K., Hajjar, R. J., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.04.010 · Cited by 142 · cited 1×
“Members of the CCN protein family may play contrasting roles in fibrosis (14, 49).”
BackgroundRegulation of hepatic stellate cells by connective tissue growth factor
Huang, G. (2012) · Frontiers in Bioscience · doi:10.2741/4067 · Cited by 135
Higashiyama, R., Moro, T., Nakao, S., Mikami, K., Fukumitsu, H., Ueda, Y., Ikeda, K., Adachi, E., Bou–Gharios, G., Okazaki, I., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.006 · Cited by 134 · cited 1×
“Bone marrow-derived cells and epithelial cells may also differentiate into myofibroblasts (5, 6), although the extents of their contribution to liver fibrosis have been controversial (7, 8).”
BackgroundConnective tissue growth factor (CCN2, CTGF) and organ fibrosis: lessons from transgenic animals
Brigstock, D. R. (2010) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-009-0071-5 · Cited by 134 · cited 1×
“CCN2/CTGF, a homolog of CCN1, has been shown to be a profibrotic regulator whose high expression is associated with fibrosis of many organs and tissues, including the liver (50).”
BackgroundIdentification of a novel integrin α6β1 binding site in the angiogenic Inducer CCN1 (CYR61)
Leu, S.-J., Liu, Y., Chen, N., Chen, C.-C., Lam, S. C.-T., & Lau, L. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305862200 · Cited by 131 · cited 1×
“Finally, an 6 1-binding peptide (T1) (40) that competes with ligand binding to 6 1 abrogated CCN1-induced senescence, whereas a mutated T1 peptide that does not bind 6 1 had no effect (Fig.”
BackgroundSelf-citationFibrogenic Potential of Human Multipotent Mesenchymal Stromal Cells in Injured Liver
Baertschiger, R. M., Serre-Beinier, V., Morel, P., Bosco, D., Peyrou, M., Clément, S., Sgroi, A., Kaelin, A., Buhler, L. H., & Gonelle-Gispert, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006657 · Cited by 121 · cited 1×
“Bone marrow-derived cells and epithelial cells may also differentiate into myofibroblasts (5, 6), although the extents of their contribution to liver fibrosis have been controversial (7, 8).”
BackgroundCui, W., Matsuno, K., Iwata, K., Ibi, M., Matsumoto, M., Zhang, J., Zhu, K., Katsuyama, M., Torok, N. J., & Yabe-Nishimura, C. (2011) · Hepatology · doi:10.1002/hep.24465 · Cited by 113 · cited 2×
“Thus, although NOX1-induced ROS have been shown to promote HSC activation and stimulate liver fibrogenesis (44, 45), they may also be critical for the regression of fibrosis.”
BackgroundThe Matricellular Protein CCN1 Is Essential for Cardiac Development
Mo, F.-E., & Lau, L. F. (2006) · Circulation Research · doi:10.1161/01.res.0000248426.35019.89 · Cited by 112 · cited 1×
“Since Ccn1 is essential for cardiovascular development, germ line Ccn1 knockout mice are embryonic lethal (33, 34).”
BackgroundSelf-citationAthanasopoulos, A. N., Schneider, D., Keiper, T., Alt, V., Pendurthi, U. R., Liegibel, U. M., Sommer, U., Nawroth, P. P., Kasperk, C., & Chavakis, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705200200 · Cited by 99 · cited 2×
“CCN1 is an angiogenic inducer involved in skin wound healing and bone fracture repair (32, 46).”
BackgroundAssessing the Metabolic Competence of Sandwich-Cultured Mouse Primary Hepatocytes
Mathijs, K., Kienhuis, A. S., Brauers, K. J. J., Jennen, D. G. J., Lahoz, A., Kleinjans, J. C. S., & van Delft, J. H. M. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.025775 · Cited by 78 · cited 1×
“Hepatocytes were isolated by a two-step collagenase perfusion method as previously described (25).”
MethodTargeted Mutagenesis of the Angiogenic Protein CCN1 (CYR61)
Leu, S.-J., Chen, N., Chen, C.-C., Todorović, V., Bai, T., Juric, V., Liu, Y., Yan, G., Lam, S. C.-T., & Lau, L. F. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407850200 · Cited by 72
Self-citationJuric, V., Chen, C.-C., & Lau, L. F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00064-09 · Cited by 70 · cited 1×
“cence microscopy as previously described (30).”
Self-citation血管新生蛋白質CCN1(CYR61)の標的突然変異形成 インテグリンα 6 β 1 -ヘパラン硫酸プロテオグリカン共受容体介在性細胞機能の選択的不活性化
S‐J, L., Chen, N., Cc, C., et al. (2004) · Journal of Biological Chemistry · Cited by 2
Research works printed but not linked: 3
- Constandinou C, 2005, Methods Mol. Med., 117, 237
- Kountouras J, 1984, Br. J. Exp. Pathol., 65, 305
- Weiskirchen R, 2005, Methods Mol. Med., 117, 99
Cited by
Cellular senescence: from physiology to pathology
Muñoz-Espín, D., & Serrano, M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3823 · Cited by 2,818
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
Di Micco, R., Krizhanovsky, V., Baker, D., & d’Adda di Fagagna, F. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00314-w · Cited by 2,277
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
“The upstream signals that induce senescence after wounding are not yet known, although activation of the matricellular protein CCN1 was shown to induce senescence during skin and liver repair (Jun and Lau, 2010; Kim et al., 2013).”
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485
“ROS accumulation through Rac1-NADPH oxidase 1 enzyme complex in HSCs [142].”
BackgroundCellular Senescence: Aging, Cancer, and Injury
Calcinotto, A., Kohli, J., Zagato, E., Pellegrini, L., Demaria, M., & Alimonti, A. (2019) · Physiological Reviews · doi:10.1152/physrev.00020.2018 · Cited by 1,270
“Mice treated with recombinant CCN1, IL-22, or IGF-1 displayed accelerated fibrotic resolution (182, 186, 245), suggesting that prosenescence therapies could be promising agents to resolve liver fibrosis.”
Background
Metadata
- Authors
- Kim, K.-H., Chen, C.-C., Monzon, R. I., & Lau, L. F.
- Affiliations
- Department of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, Illinois, USA
- University of Illinois Chicago (US)
- ORCID
- Lau, Lester F.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2013-05-01
- Volume
- 33
- Issue
- 10
- Pages
- 2078-2090
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC3647960
- OpenAlex
- W2160370983
- Cited by
- 261
- References
- 57
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 10 · 2023: 17 · 2022: 18 · 2021: 26 · 2020: 24 · 2019: 17 · 2018: 20 · 2017: 27 · 2016: 27 · 2015: 23 · 2014: 24 · 2013: 6
- FWCI
- 16.60
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of General Medical Sciences (R01GM078492, GM78492)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR061791, AR61791)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connective Tissue Growth Factor Research
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- CYR61, liver fibrosis, fibrosis regression, cellular senescence, hepatic stellate cells, portal fibroblasts, alpha6beta1 integrin, Rac1, NOX1, reactive oxygen species, CCN family, hepatocyte-specific deletion, carbon tetrachloride, bile duct ligation, liver cirrhosis, antifibrotic therapy
- MeSH terms
- NADPH Oxidase 1, Animals, Binding Sites, Carbon Tetrachloride, Cells, Cultured, Cholestasis, Female, Humans, Liver, Liver Cirrhosis, Male, Mice, Inbred C57BL, Mice, Transgenic, NADH, NADPH Oxidoreductases, Neuropeptides, Signal Transduction, Cellular Senescence, Reactive Oxygen Species, rac GTP-Binding Proteins, rac1 GTP-Binding Protein, Integrin alpha6beta1, Tissue Array Analysis, Mice, Hepatic Stellate Cells, Cysteine-Rich Protein 61, Mice, 129 Strain, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.